Trial Details

RECRUITING
Basic Information
Clinical ID c206
Identifier NCT06964113
Trial Title A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Filgotinib Maleate
Participant Information
Sponsor Eisai Korea Inc.
City Busan
Country/Region South Korea
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2025-06-11
Primary Completion Date 2027-11-30
Completion Date 2027-11-30